SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-022126
Filing Date
2016-08-03
Accepted
2016-08-02 18:34:49
Documents
41
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cort-10q_20160630.htm 10-Q 1088206
2 EX-31.1 cort-ex311_35.htm EX-31.1 15329
3 EX-31.2 cort-ex312_34.htm EX-31.2 15328
4 EX-32.1 cort-ex321_33.htm EX-32.1 6733
5 EX-32.2 cort-ex322_32.htm EX-32.2 6576
  Complete submission text file 0001564590-16-022126.txt   3144232

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cort-20160630.xml EX-101.INS 569168
7 XBRL TAXONOMY EXTENSION SCHEMA cort-20160630.xsd EX-101.SCH 22214
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cort-20160630_cal.xml EX-101.CAL 35591
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cort-20160630_def.xml EX-101.DEF 38631
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20160630_lab.xml EX-101.LAB 160094
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20160630_pre.xml EX-101.PRE 120348
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 161801839
SIC: 2834 Pharmaceutical Preparations